The Motley Fool Discussion Boards

Previous Page

Stocks B / Boston Scientific Corp.


Subject:  BSX Receives FDA Clearance for WallFlex Date:  11/20/2009  1:28 PM
Author:  robbyyy21212121 Number:  446 of 448

Boston Scientific has received 510(k) clearance from the US Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex fully covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
Copyright 1996-2018 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us